Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychotics.
Cai J, Li L, Shao T, Sun M, Wang W, Xie P, Wang X, Yang Y, Long Y, Kang D, Xiao J, Su Y, Peng X, Huang Y, Gao M, Wu Q, Song C, Liu F, Shao P, Ou J, Shen Y, Huang J, Wu R.
Cai J, et al. Among authors: wu r, wu q.
Psychiatry Res. 2023 Apr;322:115138. doi: 10.1016/j.psychres.2023.115138. Epub 2023 Mar 1.
Psychiatry Res. 2023.
PMID: 36871411